On Aug. 21, 2024, in In re Amitiza Antitrust Litig.,
the United States District Court for the District of Massachusetts
dismissed a c.93A claim brought by a putative class of indirect
purchasers of certain pharmaceuticals for lack of standing under
the Illinois Brick indirect purchaser bar. Under the
Illinois Brick doctrine, an indirect purchaser, i.e.,
someone who purchases a product somewhere down the supply chain,
does not have standing to bring federal antitrust claims.
In considering the Massachusetts consumer protection claims, the
court noted that an indirect purchaser was also barred from
bringing claims under the Massachusetts Antitrust Act and against
persons engaged in the conduct of any trade or commerce under Mass.
Gen. Laws. Ch. 93A, Section 11.